[go: up one dir, main page]

WO2008007321A2 - Cross-linked chitosan and process to cross-link - Google Patents

Cross-linked chitosan and process to cross-link Download PDF

Info

Publication number
WO2008007321A2
WO2008007321A2 PCT/IB2007/052659 IB2007052659W WO2008007321A2 WO 2008007321 A2 WO2008007321 A2 WO 2008007321A2 IB 2007052659 W IB2007052659 W IB 2007052659W WO 2008007321 A2 WO2008007321 A2 WO 2008007321A2
Authority
WO
WIPO (PCT)
Prior art keywords
chitosans
ranges
degree
suspension
aliphatic aldehyde
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2007/052659
Other languages
French (fr)
Other versions
WO2008007321A3 (en
Inventor
Cosmo Mezzina
Giovanni Scapagnini
Ivo Volpato
Bernard Bizzini
Giovanni Franchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirc SpA Natural & Dietetic Foods
Original Assignee
Sirc SpA Natural & Dietetic Foods
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sirc SpA Natural & Dietetic Foods filed Critical Sirc SpA Natural & Dietetic Foods
Priority to EP07805070A priority Critical patent/EP2044127A2/en
Publication of WO2008007321A2 publication Critical patent/WO2008007321A2/en
Publication of WO2008007321A3 publication Critical patent/WO2008007321A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Definitions

  • This invention relates to chitosans, which are polymers of D-glucosamine, in crosslinked form, and to a process for producing chitosans in crosslinked form.
  • Said polymers are a basic component of some diet supplements, possibly in association with other compounds, used to produce cholesterol-lowering and lipid-lowering effects and to reduce sugar absorption and body weight, as described, for example, in Italian patent 1284638 filed by the Applicant.
  • the chitosans are poly( ⁇ - 1 ,4-glucosamine).
  • chitosans are crosslinkable.
  • the crosslinking reaction involves the free amine functional groups present in the macromolecule of the chitosans. These functional groups react with a suitable crosslinker, forming stable bonds with them.
  • chitosans cross-linked according to this invention have crosslinking bonds which are irreversible under the physiological conditions of the human body.
  • the crosslinked chitosans according to this invention compared with the non-crosslinked form, therefore cannot be attacked or degraded (or are attacked or degraded to a much lesser extent) by digestive enzymes and/or the physiological conditions of the gastrointestinal tract, such as the pH. As a result, said chitosans pass through the entire digestive apparatus practically unchanged.
  • This invention consequently relates to chitosans in crosslinked form wherein the crosslink derives from the reaction of said polymer with a crosslinker chosen from among the group of aliphatic aldehydes.
  • the crosslinked chitosans according to this invention can have a very broad range of crosslinking, from totally cross-linked to very slight crosslinking.
  • degree of crosslinking means the ratio between the number of functional amine groups (-NH2) which have reacted with a functional aldehyde group of the crosslinker and the total number of functional amine groups present in the polymer.
  • the crosslinked chitosans according to the invention have a degree of crosslinking which varies between approximately 1 :10 and 1 :200, preferably between 1 :30 and 1 :150, and more preferably between 1 :60 and 1 :120.
  • the aliphatic aldehyde is preferably a hydrocarbon with a C1-C10 alky] chain.
  • the aldehyde is preferably chosen from among the monoaldehydes and dialdehydes.
  • the preferred example of monoaldehyde is formaldehyde.
  • the particularly preferred example of dialdehydes is glutaraldehyde ((OHC-(CH 2 )S-CHO)).
  • Any chitosan can be crosslinked.
  • the crosslinked chitosans used according to this invention have an apparent density which ranges between approximately 0.3 and 0.80 g/ml, and preferably between 0.5 and 0.7 g/ml.
  • the particle size of these polymers typically ranges between 80 and 400 mesh, and preferably between 80 and 20 mesh.
  • the chitosans have a degree of deacetylation which typically ranges between 89 and 95%, but those with a degree of deacetylation exceeding 90% are preferred.
  • the crosslinking process which is a further subject of this invention, comprises the following stages:
  • Said buffer solution is obtained by adding acid salts of alkaline metals to the water, preferably a pair of sodium acid phosphates, namely Na 2 HPO 4 and NaH 2 PO 4 , or the sodium carbonate/bicarbonate pair.
  • Said buffer solution has a salt molarity of between approximately 0.01 and 0.5, and preferably between 0.05 and 0.1.
  • the quantity of aliphatic aldehyde reacted with the polymer to be crosslinked is chosen on the basis of the degree of crosslinking to be obtained and the number of functional aldehyde groups in the molecule.
  • the ratio between chitosan and crosslinker, expressed as moles of glucose contained in the polymer compared with the moles of crosslinker, typically ranges between 1 :1 -1CM and 1 :1 -10- 3 .
  • the crosslinker can be added, for example, in the form of an aqueous solution.
  • the molarity of the crosslinker namely the aldehyde, can range, for example, between 0.1 and 10, and preferably between 0.5 and 2.
  • Said organic amine compound is preferably an aminoacid, such as glycine or lysine. Said amine compound is added greatly in excess of the aldehyde functions which have not yet reacted; it is generally a solution which has approximately the same molarity as the solution containing the aldehyde.
  • the suspension is preferably stirred at stages (2) and (3).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

The present invention relates to Chitosans in crosslinked form wherein the crosslink derives from the reaction of said chitosans with a crosslinker chosen from among the group of aliphatic aldehydes, and to a Chitosan crosslinking process comprising the following stages: 1) suspend chitosan in a buffer solution having a pH that ranges between 7.5 and 9.5, preferably between 8.0 and 9.0, and more preferably between 8.1 and 8.3 (suspension 1); 2) place suspension (1) in contact with an aliphatic aldehyde as crosslinker and leave to react for 1 to 24 hours at a temperature of between 15- and 40 -C (suspension 2); and possibly: 3) treat suspension (2) with an organic amine compound.

Description

Description
[01] This invention relates to chitosans, which are polymers of D-glucosamine, in crosslinked form, and to a process for producing chitosans in crosslinked form.
[02] Said polymers are a basic component of some diet supplements, possibly in association with other compounds, used to produce cholesterol-lowering and lipid-lowering effects and to reduce sugar absorption and body weight, as described, for example, in Italian patent 1284638 filed by the Applicant.
[03] More specifically, from the chemical standpoint, the chitosans are poly(β- 1 ,4-glucosamine).
[04] It has now surprisingly been found that the chitosans are crosslinkable. The crosslinking reaction involves the free amine functional groups present in the macromolecule of the chitosans. These functional groups react with a suitable crosslinker, forming stable bonds with them. In particular, chitosans cross-linked according to this invention have crosslinking bonds which are irreversible under the physiological conditions of the human body. The crosslinked chitosans according to this invention, compared with the non-crosslinked form, therefore cannot be attacked or degraded (or are attacked or degraded to a much lesser extent) by digestive enzymes and/or the physiological conditions of the gastrointestinal tract, such as the pH. As a result, said chitosans pass through the entire digestive apparatus practically unchanged.
[05] This invention consequently relates to chitosans in crosslinked form wherein the crosslink derives from the reaction of said polymer with a crosslinker chosen from among the group of aliphatic aldehydes.
[06] The crosslinked chitosans according to this invention can have a very broad range of crosslinking, from totally cross-linked to very slight crosslinking. In this invention, "degree of crosslinking" means the ratio between the number of functional amine groups (-NH2) which have reacted with a functional aldehyde group of the crosslinker and the total number of functional amine groups present in the polymer.
[07] The crosslinked chitosans according to the invention have a degree of crosslinking which varies between approximately 1 :10 and 1 :200, preferably between 1 :30 and 1 :150, and more preferably between 1 :60 and 1 :120.
[08] The aliphatic aldehyde is preferably a hydrocarbon with a C1-C10 alky] chain. The aldehyde is preferably chosen from among the monoaldehydes and dialdehydes. The preferred example of monoaldehyde is formaldehyde. The particularly preferred example of dialdehydes is glutaraldehyde ((OHC-(CH2)S-CHO)).
[09] Any chitosan can be crosslinked. The crosslinked chitosans used according to this invention have an apparent density which ranges between approximately 0.3 and 0.80 g/ml, and preferably between 0.5 and 0.7 g/ml. The particle size of these polymers typically ranges between 80 and 400 mesh, and preferably between 80 and 20 mesh. The chitosans have a degree of deacetylation which typically ranges between 89 and 95%, but those with a degree of deacetylation exceeding 90% are preferred.
[010] The crosslinking process, which is a further subject of this invention, comprises the following stages:
[011] 1) suspend chitosan in a buffer solution having a pH that ranges between 7.5 and 9.5, preferably between 8.0 and 9.0, and more preferably between 8.1 and 8.3 (suspension 1);
[012] 2) place suspension (1) in contact with an aliphatic aldehyde as crosslinker and leave to react for 1 to 24 hours, preferably 1 to 18 hours, and more preferably 1 to 2 hours, at a temperature of between 15° and 40°C, and preferably between 20 and 27°C (suspension 2); and possibly:
[013] 3) treat suspension (2) with an organic amine compound.
[014] Said buffer solution is obtained by adding acid salts of alkaline metals to the water, preferably a pair of sodium acid phosphates, namely Na2HPO4 and NaH2PO4, or the sodium carbonate/bicarbonate pair.
[015] Said buffer solution has a salt molarity of between approximately 0.01 and 0.5, and preferably between 0.05 and 0.1.
[016] The quantity of aliphatic aldehyde reacted with the polymer to be crosslinked is chosen on the basis of the degree of crosslinking to be obtained and the number of functional aldehyde groups in the molecule. The ratio between chitosan and crosslinker, expressed as moles of glucose contained in the polymer compared with the moles of crosslinker, typically ranges between 1 :1 -1CM and 1 :1 -10-3.
[017] For example, if 100 g of chitosan (corresponding to 6.17 x 10"1 of glucose) is reacted with 6.17 x 10-2 moles of glutaraldehyde, a crosslinking ratio of 1:10 will be obtained, while a crosslinking ratio of 1 :200 is obtained by reacting 100 g of chitosan with 3.085 x 10'3 moles of glutaraldehyde.
[018] The crosslinker can be added, for example, in the form of an aqueous solution. In said solution the molarity of the crosslinker, namely the aldehyde, can range, for example, between 0.1 and 10, and preferably between 0.5 and 2.
[019] Said organic amine compound is preferably an aminoacid, such as glycine or lysine. Said amine compound is added greatly in excess of the aldehyde functions which have not yet reacted; it is generally a solution which has approximately the same molarity as the solution containing the aldehyde.
[020] The suspension is preferably stirred at stages (2) and (3).
[021] Non-limiting examples of this invention are set out below. The following test methods were used to define this invention:
- degree of crosslinking: the -N Hb functions still free are titrated with Habeeb's dinitrobenzene sulphonate (DNBS) method (reference A.G.S.A. Anal. Biochim., 1966, 14, 328-336). The number of -NH2 functions in the titrated polymer being known, the degree of crosslinking is calculated;
- apparent density: measured using an ERWEKA SVM 202 densitometer, SERIAL NUMBER 113260.03ec, with the following method:
I. place a known quantity in weight of the powder to be tested in the graduated cylinder of the instrument; 1. set the number of strokes of the instrument to 250; [022] III. start the instrument;
1. read the volume occupied by the powder on the graduated cylinder; and 2. calculate the apparent density of the powder under test with the following formula:
[023] APPARENT DENSITY = MASS / VOLUME = g / ml [024] Characteristics of the polymers used in the examples:
- chitosan: apparent density 0.6 g/ml, particle size 100 mesh and degree of deacetylation 95%, and
- chitin: apparent density 0.6 g/ml and particle size 100 mesh. [025] Example 1
[026] Introduce 10 kg of chitosan into an apparatus equipped with a stirrer and pour 100 I of an aqueous solution of 0.07 M Na2HPO4 at pH 8.2 onto it. Begin stirring and add 1 I of an aqueous solution of 1 M glutaraldehyde to the suspension thus obtained. Leave to react at ambient temperature for 6 hours, maintaining stirring. Stop the reaction by adding excess glycine (1 I) and filter the suspension through a Bϋckner filter to separate the chitosan from the reaction liquid; then wash with water until all trace of unreacted glutaraldehyde has been eliminated. Under said conditions, the degree of crosslinking is 1 :120.
[027] Example 2
[028] Repeat example 1 , with the sole difference that 2 I of an aqueous solution of glutaraldehyde is added instead of 1 I.
[029] A crosslinked chitosan with a degree of crosslinking of 1:60 will be obtained.

Claims

Claims
1. Chitosans in crosslinked form wherein the crosslink derives from the reaction of said chitosans with a crosslinker chosen from among the group of aliphatic aldehydes.
2. The chitosans claimed in claim 1 , wherein the aliphatic aldehyde is a hydrocarbon with a d-C-io alkyl chain.
3. The chitosans claimed in claim 2, wherein the aliphatic aldehyde is chosen from among the monoaldehydes and dialdehydes.
4. The chitosans claimed in claim 2, wherein the aliphatic aldehyde is chosen from formaldehyde and glutaraldehyde.
5. The chitosans claimed in claims 1 to 5, wherein the degree of crosslinking ranges between approximately 1:10 and 1:200.
6. The chitosans claimed in claim 5, wherein the degree of crosslinking ranges between 1 :30 and 1 :150.
7. The chitosans claimed in claims 1 to 7, wherein the chitosans to be crosslinked have an apparent density ranging between 0.3 and 0.80 g/ml, a particle size of 80 to 400 mesh and a degree of deacetylation which typically ranges between 89 and 95%.
8. The chitosans claimed in claim 7, wherein the chitosans to be crosslinked have an apparent density ranging between 0.5 and 0.7 g/ml, a particle size of 80 to 20 mesh and a degree of deacetylation exceeding 90%.
9. Chitosan crosslinking process comprising the following stages:
1) suspend chitosan in a buffer solution having a pH that ranges between 7.5 and 9.5, preferably between 8.0 and 9.0, and more preferably between 8.1 and 8.3 (suspension 1);
2) place suspension (1) in contact with an aliphatic aldehyde as crosslinker and leave to react for 1 to 24 hours at a temperature of between 15° and 40°C (suspension 2); and possibly:
3) treat suspension (2) with an organic amine compound.
10. The process claimed in claim 9, wherein the aliphatic aldehyde is a hydrocarbon with a C1-C10 alkyl chain.
11. The process claimed in claim 10, wherein the aliphatic aldehyde is chosen from among the monoaldehydes and dialdehydes.
12. The process claimed in claim 11 , wherein the aliphatic aldehyde is chosen from formaldehyde and glutaraldehyde.
13. The process claimed in claims 9 to 12, wherein the buffer solution is an aqueous solution of acid salts of alkaline metals.
14. The process claimed in claim 13, wherein the buffer solution is formed with a pair of sodium acid phosphates or a sodium carbonate/bicarbonate pair.
15. The process claimed in claims 9 to 14, wherein the ratio between chitosan and crosslinker, expressed as 1 gram of polymer to moles of crosslinker, ranges between 1 :1 -10-1 and 1 :1 -10-3.
16. The process claimed in claims 9 to 15, wherein the reaction time at stage (2) ranges between 1 and 2 hours.
17. The process claimed in claims 9 to 16, wherein the reaction temperature at stage (2) ranges between 20 and 27°C.
18. The process claimed in claims 9 to 18, wherein the chitosans to be crosslinked have an apparent density ranging between 0.3 and 0.80 g/ml, a particle size of 80 to 400 mesh and a degree of deacetylation which typically ranges between 89 and 95%.
19. The process claimed in claims 9 to 18, wherein the chitosans to be crosslinked have an apparent density ranging between 0.5 and 0.7 g/ml, a particle size of 80 to 20 mesh and a degree of deacetylation which exceeds 90%.
PCT/IB2007/052659 2006-07-10 2007-07-06 Cross-linked chitosan and process to cross-link Ceased WO2008007321A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07805070A EP2044127A2 (en) 2006-07-10 2007-07-06 Cross-linked chitosan and process to cross-link

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI20061335 ITMI20061335A1 (en) 2006-07-10 2006-07-10 RETICULATED CHITOSAN AND RETICULATION PROCESS
ITMI2006A001335 2006-07-10

Publications (2)

Publication Number Publication Date
WO2008007321A2 true WO2008007321A2 (en) 2008-01-17
WO2008007321A3 WO2008007321A3 (en) 2008-03-20

Family

ID=38846828

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/052659 Ceased WO2008007321A2 (en) 2006-07-10 2007-07-06 Cross-linked chitosan and process to cross-link

Country Status (3)

Country Link
EP (1) EP2044127A2 (en)
IT (1) ITMI20061335A1 (en)
WO (1) WO2008007321A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018119320A1 (en) * 2016-12-21 2018-06-28 Cresilon, Inc. Hemostatic compositions with antifibrinolytic agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH596233A5 (en) * 1975-04-10 1978-03-15 Nestle Sa
US5019509A (en) * 1988-04-20 1991-05-28 Genetics Institute, Inc. Method and compositions for the production of l-alanine and derivatives thereof
US5328939A (en) * 1993-04-27 1994-07-12 Alliedsignal Inc. Rigid materials having high surface area and low density
DE19920557B4 (en) * 1999-05-05 2004-09-09 Biotec Asa Process for the production of collagen-free cosmetic preparations
WO2003042250A1 (en) * 2001-11-15 2003-05-22 Biosyntech Canada Inc. Composition and method to homogeneously modify or cross-link chitosan under neutral conditions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018119320A1 (en) * 2016-12-21 2018-06-28 Cresilon, Inc. Hemostatic compositions with antifibrinolytic agents

Also Published As

Publication number Publication date
ITMI20061335A1 (en) 2008-01-11
EP2044127A2 (en) 2009-04-08
WO2008007321A3 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
Heras et al. N-methylene phosphonic chitosan: a novel soluble derivative
Lawal et al. Carboxymethyl cocoyam starch: synthesis, characterisation and influence of reaction parameters
JP5886754B2 (en) Method for preparing oxidized derivative of hyaluronic acid and method for modifying the same
RU2550602C2 (en) Hyaluronic acid derivative, method of obtaining and modification thereof
CA2092141C (en) Process for the oxidation of cationic starches; amphoteric carboxylic and cationic starches thus produced
WO2000026257A1 (en) Carbohydrate oxidation products and derivatives
CN101343334A (en) The preparation method of O-2'-hydroxypropyltrimethylammonium chloride chitosan
Zampano et al. Defined Chitosan-based networks by C-6-Azide–alkyne “click” reaction
CN107216408A (en) Preparation method of antibacterial functionalized chitosan derivative
JP2015143311A (en) Method for producing cyclodextrin grafted chitosan
EP2044127A2 (en) Cross-linked chitosan and process to cross-link
Kurniasih et al. Optimum conditions for the synthesis of high solubility carboxymethyl chitosan
Sashiwa et al. Chemical modification of chitosan. Part 9: Reaction of N-carboxyethylchitosan methyl ester with diamines of acetal ending PAMAM dendrimers
JP2007534783A (en) Polysaccharide derivatives and their production and use
MXPA05002252A (en) Method for producing temporarily cross-linked cellulose ethers.
CN114409828A (en) A kind of chitosan oligosaccharide aminophenylamide derivatives and preparation method thereof
Azevedo et al. Preparation and characterization of chitosans carrying aldehyde functions generated by nitrogen oxides
JP4008977B2 (en) Chitosan derivative, production method thereof and metal ion adsorbent
RU2359975C2 (en) Method for production of modified arabinogalactan
CN102153673A (en) N-parabenzyloxycarboxymethyl chitosan quaternary ammonium salt and preparation method thereof
RU2396281C2 (en) N-2-(2-pyridyl)ethylchitosan and synthesis method thereof
EP3713968B1 (en) Functionalised compounds
JP2004250543A (en) Method for producing chitosan derivative and chitosan derivative
CN114478836A (en) A kind of chitosan oligosaccharide diaminocaproamide derivatives and preparation method thereof
Kitosan DETERMINATION OF SODIUM HYDROXIDE CONCENTRATION UNDER HETEROGENEOUS CONDITIONS FOR THE PREPARATION OF N-CARBOXYMETHYL CHITOSAN

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07805070

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2007805070

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007805070

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU